FMC Valuation

Is FMQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FMQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FMQ (€55.56) is trading below our estimate of fair value (€130.29)

Significantly Below Fair Value: FMQ is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for FMQ?

Key metric: As FMQ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for FMQ. This is calculated by dividing FMQ's market cap by their current earnings.
What is FMQ's PE Ratio?
PE Ratio4.8x
EarningsUS$1.53b
Market CapUS$7.33b

Price to Earnings Ratio vs Peers

How does FMQ's PE Ratio compare to its peers?

The above table shows the PE ratio for FMQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.6x
SDF K+S
78.9x61.1%€2.0b
EVK Evonik Industries
35.8x33.1%€8.2b
FPE3 Fuchs
19.3x8.9%€5.1b
WCH Wacker Chemie
28.3x37.0%€3.5b
FMQ FMC
4.8x-17.0%€7.3b

Price-To-Earnings vs Peers: FMQ is good value based on its Price-To-Earnings Ratio (4.8x) compared to the peer average (40.6x).


Price to Earnings Ratio vs Industry

How does FMQ's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
FMQ 4.8xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: FMQ is good value based on its Price-To-Earnings Ratio (4.8x) compared to the European Chemicals industry average (16.9x).


Price to Earnings Ratio vs Fair Ratio

What is FMQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FMQ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.8x
Fair PE Ratio10.8x

Price-To-Earnings vs Fair Ratio: FMQ is good value based on its Price-To-Earnings Ratio (4.8x) compared to the estimated Fair Price-To-Earnings Ratio (10.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst FMQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€55.56
€70.81
+27.5%
15.7%€104.94€57.24n/a18
Nov ’25€59.60
€68.75
+15.4%
15.8%€101.51€55.37n/a18
Oct ’25€58.88
€67.33
+14.3%
17.4%€100.64€52.15n/a17
Sep ’25€58.86
€67.33
+14.4%
17.4%€100.64€52.15n/a17
Aug ’25€56.16
€66.50
+18.4%
20.1%€101.94€46.34n/a17
Jul ’25€53.34
€67.31
+26.2%
19.2%€102.99€46.82n/a18
Jun ’25€55.94
€67.76
+21.1%
20.6%€101.85€46.30n/a16
May ’25€56.04
€65.07
+16.1%
21.0%€103.05€49.65n/a18
Apr ’25€58.54
€62.92
+7.5%
21.5%€100.72€48.53n/a18
Mar ’25€52.62
€61.82
+17.5%
21.6%€101.66€48.98n/a19
Feb ’25€56.00
€64.60
+15.4%
19.0%€101.22€48.77n/a20
Jan ’25€56.70
€63.80
+12.5%
19.9%€100.90€48.62n/a18
Dec ’24€49.53
€66.24
+33.7%
24.6%€107.23€48.25n/a18
Nov ’24€49.93
€72.43
+45.1%
24.9%€111.47€50.15€59.6018
Oct ’24€62.10
€105.14
+69.3%
12.3%€132.43€85.13€58.8818
Sep ’24€79.12
€108.34
+36.9%
12.9%€142.26€82.60€58.8619
Aug ’24€87.80
€111.29
+26.8%
11.2%€140.12€91.30€56.1618
Jul ’24€95.98
€133.57
+39.2%
6.3%€146.90€112.28€53.3418
Jun ’24€97.92
€133.57
+36.4%
6.3%€146.90€112.28€55.9418
May ’24€110.10
€131.93
+19.8%
6.0%€143.23€109.48€56.0417
Apr ’24€110.60
€136.32
+23.3%
6.1%€149.09€112.52€58.5417
Mar ’24€121.48
€135.81
+11.8%
5.7%€148.03€111.72€52.6216
Feb ’24€121.80
€131.88
+8.3%
6.4%€142.45€102.93€56.0016
Jan ’24€116.58
€131.99
+13.2%
7.0%€143.43€105.68€56.7016
Dec ’23€124.52
€134.59
+8.1%
6.9%€146.80€108.17€49.5317
Nov ’23€120.94
€137.51
+13.7%
7.4%€151.86€113.39€49.9317

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies